Back to announcement
20251223_SOHO_Laporan Informasi dan Fakta Material_32015066_lamp3.pdf
Other Text extracted SOHOSource file signed link, expires in 15 minutes
Extracted text 5
Page 1
Jakarta, 23 Desember 2025/ 23 December 2025
No. : 915/SOHO-IDX/XII/2025
Lampiran/Attachment : -
Perihal/ Re : Laporan Informasi atau Fakta Material/ Report on Material Information
or Facts
Kepada/To:.
(i) Otoritas Jasa Keuangan
Gedung Soemitro Djojohadikusumo
Jl. Lapangan Banteng Timur No. 2-4
Jakarta 10710
u.p./attn. : Kepala Eksekutif Pengawas Pasar Modal/ Chief Executive of Capital Market
Supervision
(ii) PT Bursa Efek Indonesia
Gedung Bursa Efek Indonesia Menara I Lantai 6
Jl. Jend Sudirman Kav. 52-53
Jakarta 12190
u.p./attn. : Direktur Penilaian Perusahaan/ Director of Company Valuation
Dengan hormat, Dear Messrs,
Untuk memenuhi ketentuan Peraturan In compliance with the provisions of
Otoritas Jasa Keuangan (POJK) No. Financial Services Authority Regulation
31/POJK.04/2015 tentang Keterbukaan atas (POJK) No. 31/POJK.04/2015 concerning
Informasi atau Fakta Material oleh Emiten the Disclosure of Information or Material
atau Perusahaan Publik dan POJK No. 45 Facts by Issuers or Public Companies and
Tahun 2024 tentang Pengembangan dan POJK No. 45 of 2024 concerning the
Penguatan Emiten dan Perusahaan Publik Development and Strengthening of Issuers
dengan ini kami untuk dan atas nama PT. and Public Companies, we hereby, for and
Soho Global Health Tbk (“Perseroan”) on behalf of PT Soho Global Health Tbk (the
menyampaikan Laporan Informasi atau “Company”), submit the Report on
Fakta Material (“Laporan”) sebagai Information or Material Facts (the
berikut: “Report”) as follows:
Nama Emiten/ Name of Issuer : PT. SOHO GLOBAL HEALTH TBK
Bidang Usaha/ Line of Business : Kesehatan/ Industri Farmasi/ Healthcare/
Pharmaceutical Industry
Telepon/ Telephone Number : (021) 4683 2588
Faksimili/ Faximile : (021) 4683 2589
Alamat surat elektronik/ E-mail address: corporate.secretary@sohoglobalhealth.com
Page 2
1. Tanggal Kejadian/ Date of 23 Desember 2025/ 23 December 2025
Event
2. Jenis Informasi atau Fakta Informasi atau Fakta Material lainnya, yakni
Material/ Type of Material pendapatan berupa dividen interim dari anak
Information or Facts perusahaan Perseroan/
Other Material Information or Facts, namely income in
the form of interim dividends from the Company's
subsidiaries
3. Uraian Informasi atau Fakta 1. - Nama Pihak Pemberi Dividen Interim/ Interim
Material/ Description of Dividend Payer Name
Material Information or PT. Soho Industri Pharmasi
Fact
- Jumlah Dividen Interim yang Diterima/
Amount of Interim Dividend Received
Rp179.470.000.000,- (seratus tujuh puluh
sembilan milyar empat ratus tujuh puluh juta
Rupiah)/ IDR 179,470,000,000 (one hundred
seventy-nine billion four hundred seventy million
Rupiah)
- Hubungan Afiliasi/ Affiliated Relationship
PT. Soho Industri Pharmasi adalah anak
perusahaan dari Perseroan dengan kepemilikan
saham sebesar 99,64%
PT. Soho Industri Pharmasi is a subsidiary of the
Company with 99.64% shares ownership
- Keterangan/ Information
Penerimaan dividen interim ini berdasarkan
Keputusan Sirkuler Sebagai Pengganti Rapat
Direksi dan Rapat Dewan Komisaris PT. Soho
Industri Pharmasi tertanggal 23 Desember 2025,
yang mana Direksi dan Dewan Komisaris PT.
Soho Industri Pharmasi telah menyetujui
penetapan dan pembagian dividen interim untuk
Tahun Buku 2025, kepada masing-masing
pemegang saham PT. Soho Industri Pharmasi
(termasuk Perseroan) dan untuk seluruh seri
saham (saham seri A dan seri B) dengan total
sebesar Rp180.125.000.000,- (seratus delapan
puluh milyar seratus dua puluh lima juta Rupiah)
atau Rp 655.000.000,- (enam ratus lima puluh
lima juta Rupiah) per lembar saham.
This interim dividend income is based on
Circular Resolutions in Lieu of the Board of
Page 3
Directors and Board of Commissioners’ Meeting
of PT. Soho Industri Pharmasi dated 23
December 2025, wherein the Board of Directors
and Board of Commissioners of PT. Soho Industri
Pharmasi has approved the determination and
distribution of interim dividends for the Financial
Year of 2025, to each shareholder of PT. Soho
Industri Pharmasi (including the Company) and
for all series of shares (series A and series B) with
a total of IDR180,125,000,000 (one hundred
eighty billion one hundred twenty-five million
Rupiah) or IDR655,000,000 (six hundred fifty-
five million Rupiah) per share.
2. - Nama Pihak Pemberi Dividen Interim/ Interim
Dividend Payer Name
PT. Parit Padang Global
- Jumlah Dividen Interim yang Diterima/
Amount of Interim Dividend Received
Rp240.889.727.500,- (dua ratus empat puluh
milyar delapan ratus delapan puluh sembilan juta
tujuh ratus dua puluh tujuh ribu lima ratus
Rupiah)/ (two hundred forty billion eight hundred
eighty-nine million seven hundred twenty-seven
thousand five hundred Rupiah)
- Hubungan Afiliasi/ Affiliated Relationship
PT. Parit Padang Global adalah anak perusahaan
dari Perseroan dengan kepemilikan saham
sebesar 99,9999%.
PT. Parit Padang Global is a subsidiary of the
Company with 99.9999% shares ownership.
- Keterangan/ Information
Penerimaan dividen interim ini berdasarkan
Keputusan Sirkuler Sebagai Pengganti Rapat
Direksi dan Rapat Dewan Komisaris PT. Parit
Padang Global tertanggal 23 Desember 2025,
yang mana Direksi dan Dewan Komisaris PT.
Parit Padang Global telah menyetujui penetapan
dan pembagian dividen interim untuk Tahun
Buku 2025, kepada masing-masing pemegang
saham PT. Parit Padang Global (termasuk
Perseroan) untuk seluruh seri saham (saham seri
A dan seri B) dengan total Rp240.890.000.000,-
(dua ratus empat puluh milyar delapan ratus
Page 4
sembilan puluh juta Rupiah) atau Rp272.500,-
(dua ratus tujuh puluh dua ribu lima ratus Rupiah)
per lembar saham
This interim dividend income is based on
Circular Resolutions in Lieu of the Board of
Directors and Board of Commissioners’ Meeting
of PT. Parit Padang Global dated 23 December
2025, wherein the Board of Directors and Board
of Commissioners of PT. Parit Padang Global
have approved the determination and distribution
of interim dividends for the Financial Year of
2025, to each shareholder of PT. Parit Padang
Global (including the Company) and for all
series of shares (series A and series B) with a
total of IDR240,890,000,000 (two hundred forty
billion eight hundred ninety million Rupiah) or
IDR272,500 (Two hundred seventy-two thousand
five hundred Rupiah) per share.
4. Dampak kejadian, informasi Pendapatan berupa dividen interim dari anak
atau fakta material tersebut perusahaan Perseroan, yakni PT. Soho Industri
Pharmasi dan PT. Parit Padang Global sebagaimana
terhadap kegiatan
disebutkan di atas, tidak berdampak material, baik
operasional, hukum, kondisi terhadap kegiatan operasional, hukum, kondisi
keuangan, atau keuangan, atau kelangsungan usaha Perseroan.
kelangsungan usaha Emiten Income in the form of interim Dividends from the
atau Perusahaan Publik/ The subsidiaries of the Company, namely PT. Soho
impact of the event, material Industri Pharmasi and PT. Parit Padang Global as
information or facts on the mentioned above, does not have a material impact,
either on the operational activities, legal, financial
operational activities, legal,
condition, or business continuity of the Company.
financial condition or
business continuity of the
Issuer
5. Keterangan lain-lain/ Other -
Information
Page 5
Demikian keterbukaan informasi yang dapat kami sampaikan. Kami ucapkan terimakasih atas
perhatian dan kerjasamanya./ Thus the disclosure of information that we can provide. Thank you
for your attention and cooperation.
Hormat kami/ Sincerely,
PT. SOHO GLOBAL HEALTH TBK
Yuliana
Direktur/ Director
Names mentioned 9 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.1
unresolved
org
PT. Soho Industri Pharmasi Fact
p.2
unresolved
org
PT. Soho Industri Pharmasi
p.2 ×9
unresolved
org
PT. Soho
p.4
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.